Payment overview · 2025
General Payments
$65.68
3 reported records · 2 companies
Healthcare provider profile · identity verified
Nathan A Watson, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SHERMAN, TX · NPI 1467464503
Verified facts
What the public records show
CMS Open Payments records show Nathan A Watson, MD received $65.68 in general payments during 2025 across 3 reported records.
Novo Nordisk Inc accounted for 75.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $49.38 | 75.2% | 2 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $16.30 | 24.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $65.68 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $49.38 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $49.38 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $16.30 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 18 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 880 | 111 |
| Potassium Chloride | Potassium Chloride | 876 | 145 |
| Atorvastatin Calcium | Atorvastatin Calcium | 819 | 146 |
| Furosemide | Furosemide | 729 | 110 |
| Eliquis | Apixaban | 578 | 71 |
| Gabapentin | Gabapentin | 574 | 95 |
| Amlodipine Besylate | Amlodipine Besylate | 468 | 89 |
| Trazodone Hcl | Trazodone Hcl | 463 | 89 |
| Pantoprazole Sodium | Pantoprazole Sodium | 462 | 99 |
| Metoprolol Tartrate | Metoprolol Tartrate | 416 | 90 |
| Divalproex Sodium | Divalproex Sodium | 401 | 60 |
| Memantine Hcl | Memantine Hcl | 391 | 57 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 389 | 88 |
| Clopidogrel | Clopidogrel Bisulfate | 374 | 63 |
| Sertraline Hcl | Sertraline Hcl | 334 | 56 |
| Losartan Potassium | Losartan Potassium | 301 | 59 |
| Donepezil Hcl | Donepezil Hcl | 295 | 49 |
| Metoprolol Succinate | Metoprolol Succinate | 293 | 56 |
| Torsemide | Torsemide | 290 | 53 |
| Mirtazapine | Mirtazapine | 281 | 57 |
| Tramadol Hcl | Tramadol Hcl | 274 | 56 |
| Lisinopril | Lisinopril | 255 | 48 |
| Tamsulosin Hcl | Tamsulosin Hcl | 251 | 50 |
| Buspirone Hcl | Buspirone Hcl | 248 | 43 |
| Citalopram Hbr | Citalopram Hydrobromide | 240 | 38 |
| Quetiapine Fumarate | Quetiapine Fumarate | 230 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 208 | 37 |
| Spironolactone | Spironolactone | 208 | 36 |
| Levetiracetam | Levetiracetam | 203 | 32 |
| Metformin Hcl | Metformin Hcl | 194 | 34 |
| Risperidone | Risperidone | 194 | 17 |
| Montelukast Sodium | Montelukast Sodium | 187 | 33 |
| Prednisone | Prednisone | 185 | 89 |
| Alprazolam | Alprazolam | 180 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 172 | 28 |
| Carvedilol | Carvedilol | 171 | 38 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 169 | 62 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 151 | 32 |
| Clonazepam | Clonazepam | 137 | 27 |
| Lamotrigine | Lamotrigine | 134 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 121 | 15 |
| Benztropine Mesylate | Benztropine Mesylate | 116 | 11 |
| Allopurinol | Allopurinol | 115 | 20 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 115 | 54 |
| Budesonide | Budesonide | 114 | 26 |
| Simvastatin | Simvastatin | 114 | 23 |
| Pregabalin | Pregabalin | 112 | 20 |
| Meloxicam | Meloxicam | 111 | 21 |
| Ropinirole Hcl | Ropinirole Hcl | 111 | 13 |
| Lorazepam | Lorazepam | 109 | 20 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 108 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 105 | 50 |
| Midodrine Hcl | Midodrine Hcl | 102 | 27 |
| Farxiga | Dapagliflozin Propanediol | 98 | suppressed |
| Omeprazole | Omeprazole | 97 | 26 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 95 | 54 |
| Pravastatin Sodium | Pravastatin Sodium | 95 | 16 |
| Xarelto | Rivaroxaban | 91 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 89 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 87 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 86 | 25 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 86 | 16 |
| Fluconazole | Fluconazole | 83 | 46 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 83 | 25 |
| Jardiance | Empagliflozin | 79 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 78 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 78 | 12 |
| Olanzapine | Olanzapine | 75 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 75 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 74 | 22 |
| Latanoprost | Latanoprost | 73 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 72 | 23 |
| Sucralfate | Sucralfate | 72 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 71 | 18 |
| Levofloxacin | Levofloxacin | 69 | 50 |
| Tizanidine Hcl | Tizanidine Hcl | 69 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 68 | suppressed |
| Ranolazine Er | Ranolazine | 68 | 12 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 62 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 62 | 12 |
| Baclofen | Baclofen | 61 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 59 | 41 |
| Methocarbamol | Methocarbamol | 59 | 18 |
| Clonidine Hcl | Clonidine Hcl | 57 | 18 |
| Clindamycin Hcl | Clindamycin Hcl | 56 | 32 |
| Enulose | Lactulose | 55 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 53 | 18 |
| Topiramate | Topiramate | 52 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | 12 |
| Warfarin Sodium | Warfarin Sodium | 51 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 50 | 33 |
| Glipizide | Glipizide | 50 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 49 | suppressed |
| Nifedipine Er | Nifedipine | 49 | suppressed |
| Phenobarbital | Phenobarbital | 48 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 46 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 46 | suppressed |
| Lacosamide | Lacosamide | 45 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 44 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 44 | 11 |
| Finasteride | Finasteride | 43 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 43 | 19 |
| Famotidine | Famotidine | 42 | 15 |
| Fenofibrate | Fenofibrate | 42 | suppressed |
| Lactulose | Lactulose | 41 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 41 | 11 |
| Promethazine Hcl | Promethazine Hcl | 41 | 23 |
| Scopolamine | Scopolamine | 41 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 40 | 25 |
| Temazepam | Temazepam | 40 | 11 |
| Cephalexin | Cephalexin | 39 | 27 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 39 | 27 |
| Tolterodine Tartrate | Tolterodine Tartrate | 39 | suppressed |
| Azithromycin | Azithromycin | 38 | 30 |
| Ondansetron Odt | Ondansetron | 38 | 24 |
| Diazepam | Diazepam | 37 | suppressed |
| Nystatin | Nystatin | 37 | 25 |
| Sodium Chloride | 0.9 % Sodium Chloride | 37 | 23 |
| Albuterol Sulfate | Albuterol Sulfate | 36 | 16 |
| Bupropion Xl | Bupropion Hcl | 35 | suppressed |
| Novolog Flexpen | Insulin Aspart | 35 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 34 | suppressed |
| Ezetimibe | Ezetimibe | 33 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | 16 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 33 | suppressed |
| Acyclovir | Acyclovir | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | suppressed |
| Ibuprofen | Ibuprofen | 31 | 14 |
| Incruse Ellipta | Umeclidinium Bromide | 31 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 31 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 31 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 31 | suppressed |
| Bumetanide | Bumetanide | 30 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 29 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 29 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 29 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 28 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | 21 |
| Digoxin | Digoxin | 27 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | 14 |
| Calcitriol | Calcitriol | 25 | suppressed |
| Fentanyl | Fentanyl | 25 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 25 | suppressed |
| Lubiprostone | Lubiprostone | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 24 | suppressed |
| Multaq | Dronedarone Hcl | 24 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 24 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 23 | suppressed |
| Atenolol | Atenolol | 23 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 23 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 23 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 22 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 22 | 11 |
| Tradjenta | Linagliptin | 22 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 22 | suppressed |
| Anastrozole | Anastrozole | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Gvoke Hypopen 1-Pack | Glucagon | 21 | suppressed |
| Irbesartan | Irbesartan | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Phenytoin | Phenytoin | 21 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 20 | suppressed |
| Cilostazol | Cilostazol | 20 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 20 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 20 | suppressed |
| Vascepa | Icosapent Ethyl | 20 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 19 | suppressed |
| Linzess | Linaclotide | 19 | suppressed |
| Pentasa | Mesalamine | 19 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 18 | suppressed |
| Nystop | Nystatin | 18 | suppressed |
| Ozempic | Semaglutide | 18 | suppressed |
| Amantadine | Amantadine Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 17 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 16 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Admelog Solostar | Insulin Lispro | 15 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 15 | suppressed |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | 11 |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 15 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 15 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 15 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 15 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 15 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Leflunomide | Leflunomide | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Meropenem | Meropenem | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Np Thyroid | Thyroid,pork | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 13 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 13 | 13 |
| Brilinta | Ticagrelor | 13 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 13 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 13 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Tacrolimus | Tacrolimus | 13 | suppressed |
| Cefdinir | Cefdinir | 12 | suppressed |
| Epidiolex | Cannabidiol (Cbd) | 12 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 12 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 11 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Tobramycin Sulfate | Tobramycin Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $65.68 · 3 records | Novo Nordisk Inc | Ozempic, REXULTI, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error